Volume 11, Number 11—November 2005
Staphylococcus aureus Bacteremia, Europe
|Country||Population† (4)||% population covered by EARSS‡||Blood culture sets/1,000 inhabitants||No. SAB reported to EARSS||No. SAB for country§||SAB/100,000 inhabitants§||% MRSA|
*Only countries that provided hospital background information for at least 60% of the isolates were included; NA, not available.
‡Population coverage rate as calculated from EARSS hospitals that provided background information was adjusted for nonresponding hospitals as follows: population coverage as calculated divided by proportion of isolates with hospital background information.
§The total number of SAB per country was calculated as follows: number of S. aureus isolates in EARSS divided by adjusted proportion of population covered.
¶These rates are grossly underestimated because of the very low blood culturing rate.
- Page created: February 17, 2012
- Page last updated: February 17, 2012
- Page last reviewed: February 17, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)